Onyx Health to support Zilico’s global growth plans
Onyx Health continues to strengthen its reputation as the go to consultancy for MedTech SMEs, after being appointed by Zilico Ltd.
20th October 2017
Newcells Biotech has appointed Onyx Health to strengthen its position in the drug discovery outsourcing market. Newcells Biotech provides unique cell-based assays using induced pluripotent stem cell (iPSC) to the global drug and chemical pre-clinical market.
“A new drug can take on average over 10 years from initial discovery stage to licensing approval with each approved drug costing well in excess of £1bn to develop. As an industry, cell based assay technology using iPSCs is at an important crossroads, with the potential to significantly reduce the unpredictable and costly nature of drug discovery”, says Dr Mike Nicholds, CEO at Newcells Biotech. “At Newcells Biotech, our expertise and technology is at the forefront of the sector, and we are confident Onyx Health has the experience to further expand our business in global markets.”
Similarly, HeartScan, experts in echocardiography and sports screening has appointed Onyx Health to gain valuable insights into their customer needs.
“Onyx Health has extensive experience in health screening and access to many of the stakeholders we need to work with. They will play an important role to guide and help us to grow our business,” says Dr Antoinette Kenny, Director at HeartScan
“For some time, Onyx Health has been the agency of choice for healthcare innovators in the North-East, with Newcells Biotech and HeartScan as two perfect examples of this,” says Onyx Health Director, Karen Winterhalter. “Our knowledge of the healthcare market enables us to develop and implement sales and marketing strategies to help companies navigate the complexities of global healthcare markets, wherever they might be based.”
Onyx Health work with a broad range of healthcare clients, including life sciences, pharmaceutical, medical device, diagnostic and consumer health companies wanting to enter global and UK markets.
For more information on Onyx Health’s marketing communications services, contact us on 0191 640 3638, email firstname.lastname@example.org or visit www.onyxhealth.com.